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 INTRODUCTION 
 Although many patients with irritable bowel syndrome (IBS) 
believe that diet is important ( 1 ) and there has been some success 
with empirical diet therapy ( 2,3 ) it is only recently that a thera-
peutic diet with a clear rationale, which patients can easily under-
stand, has been widely publicized ( 4 – 8 ). Th e low-FODMAP diet 
excludes FODMAPs (Fermentable Oligo- Di-, Mono-saccharides 
And Polyols). FODMAPs include short-chain carbohydrates such 
as fructose and lactose, fructo- and galacto-oligosaccharides such 
as fructans and galactans, and polyhydric alcohols such as sorbi-
tol and mannitol ( 9 ). Th e term fructans includes carbohydrates 
with a chain length longer than 10, which are generally called 
inulins. Th ey are also excluded from the low-FODMAP diet. 
Th e current understanding is that these dietary short-chain car-
bohydrates are poorly absorbed in the small intestine, enter the 
colon, and are fermented, producing gas and distension ( 10 – 13 ). 
Furthermore, as glucose is known to enhance the absorption of 
fructose ( 14,15 ), dietary sources in which glucose is associated 
with equal amounts of fructose are allowed, whereas those with 
more fructose than glucose are excluded. Th ere is considerable 
interest in this diet as FODMAP intake (specifi cally fructose) has 
increased in Western diets over the past three decades owing to 
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increased availability of fruit and concentrated fruit juices and the 
extensive use of high-fructose corn syrup in a wide variety of proc-
essed foods and beverages, ranging from soft  drinks to yogurts 
and breads ( 16 ). Th e low-FODMAP diet has been shown to be 
eff ective in improving IBS symptoms, with one study reporting 
symptom improvements in 74 % of patients with IBS and fruc-
tose malabsorption ( 7 ), shown in a placebo controlled trial to be 
due to restriction of fructose and / or fructans ( 6 ). More recent 
studies have confi rmed these initial fi ndings, with 76 % of patients 
responding well to a restricted FODMAP intake compared with 
a historical cohort treated by conventional dietary restrictions in 
whom  ~ 50 % responded ( 4 ). Similarly, a recent small open-label 
randomized controlled trial showed a response rate of 68 % for 
the diet vs. 23 % on usual diet ( 5 ). 
 Although successful in many patients, the low-FODMAP diet is 
highly restrictive and requires intensive dietician input. Further-
more, in practice it is only a minority of the initially excluded foods 
that are ultimately excluded in the fi nal diet. Th is is likely because 
of variance in individual severity of malabsorption and bacterial 
fermentation of malabsorbed carbohydrate. Although the impact 
of oral ingestion of some FODMAPs (e.g., lactose ( 17 ) and man-
nitol ( 18 )) on increasing small bowel water has been demonstrated 
using a range of techniques, as has their malabsorption using 
breath hydrogen, it is desirable to link these events and understand 
more about the underlying mechanism. Th e ultimate aim would be 
to defi ne the mode of action of the diet and hopefully to simplify 
and tailor it better to individual patients. Th is requires an under-
standing of how the very diff erent components of the diet are 
handled by the intestine and hence cause symptoms. 
 A previous investigation using an ileostomy model has shown 
increased output of water and fermentable substrate aft er ingest-
ing a high-FODMAP diet, but did not distinguish the eff ects of 
the diff ering components ( 11 ). Furthermore, ileostomists diff er 
in many ways from intact humans as the terminal ileum under-
goes adaptation responding to chronic dehydration associated 
with ileostomy formation. Th ere is also a change in ileal bacteria 
that become more  “ colonic ” in type ( 19 ). We therefore wanted to 
investigate the action of fructose and inulin on the small bowel 
and colon in intact humans using our noninvasive magnetic reso-
nance imaging (MRI) technique. MRI can accurately measure the 
small bowel water content (SBWC) and diameter ( 13 ), and can 
also visualize gaseous distension in the colon, thereby potentially 
providing a unique correlation between symptoms and mecha-
nisms. We have previously observed that the osmotically active 
nonabsorbable disaccharide lactulose and the polyol mannitol 
both cause a marked increase in SBWC ( 13,20 ). We hypothe-
sized that the poorly absorbed osmotically active fructose would 
similarly increase small bowel water and, given the known eff ect 
of glucose on enhancing the absorption of fructose ( 21,22 ), we 
further hypothesized that adding glucose to the fructose would 
attenuate this increase in small bowel water. In contrast, the poly-
meric and osmotically inactive inulin, which is also not absorbed 
in the small bowel but fermented in the colon ( 23,24 ), would be 
predicted to not alter small bowel water but to lead to increased 
colonic gas volumes. 
 Our aims were therefore to investigate whether (i) fructose alone 
will increase SBWC compared with an equivalent mass of glucose; 
(ii) adding glucose 1:1 to fructose will reduce its eff ect on SBWC; 
and (iii) inulin would exert its greatest eff ect on the colon, having 
little eff ect on the small bowel. We aimed to improve our under-
standing of how fructose and inulin infl uence small and large 
bowel volumes that are potentially important in understanding 
how diets high in FODMAPs cause IBS symptoms. 
 METHODS 
 Study participants 
 A total of 17 healthy subjects (13 male and 4 female) with no 
history of gastrointestinal disorders were recruited. Of these, 1 
withdrew and 16 (13 male, 3 female; aged 24 ± 5 years with body 
mass index 23.3 ± 2.1  kg / m 2 ) completed the study. All subjects 
also completed the Patient Health Questionnaire 15 (PHQ 15) 
and the Hospital Anxiety and Depression Scale (HADS). Sub-
jects were screened using a MRI safety questionnaire before 
randomization. 
 Study design 
 Th is study was a four-way randomized single-blind crossover 
study, with three volunteers attending on each study day. All sub-
jects visited the study center on four separate occasions with 1 
week between each visit. Th ey were asked to fast from 20:00  h the 
previous day, and refrain from alcohol, caff eine, and strenuous 
exercise for 18  h before. Participants were further asked to refrain 
from eating bran, wheat, rye, high-FODMAP fruit and vegetables, 
beans, pulses, lentils, and excessively spicy foods on the day before 
the study, as these could stimulate bowel secretions. Th ey com-
pleted questionnaires on arrival at the center to confi rm adher-
ence to study day restrictions. In keeping with previous studies 
( 12,25 ), subjects were also asked to rinse their mouth with mouth-
wash (Corsodyl Daily, GlaxoSmithKline Consumer Healthcare, 
Brentford, UK) on arrival. Th is was to ensure that subsequent 
breath tests would not be aff ected by fermentation of the ingested 
saccharides by oral bacteria. 
 Volunteers underwent a baseline fasted scan 45  min before 
ingestion of the test meals. Th ey received the unlabeled test drink 
( t  =  0  min) and underwent a second scan 15  min later ( t  =  15  min). 
Th is was followed by a scan every hour up to  t  =  315  min. Aft er 
each scan, breath hydrogen (H 2 ) tests were performed using a 
portable hand-held breath H 2 meter (Gastro   +   Gastrolyzer, Bedfont 
Scientifi c, Kent, UK). At that time, they also completed the four-
point symptoms questionnaires scoring their feelings of abdomi-
nal gas, bloating, belching, nausea, abdominal pain, and diarrhea 
as  “ none ” (score  =  1), mild (score  =  2), moderate (score  =  3), or 
 “ severe ” (score  =  4). A fi nal symptoms questionnaire was collected 
on the day aft er the study. Aft er all procedures at the end of each 
study day, subjects were asked to swallow 75  g sweet corn (Green 
giant, General Mills UK, Uxbridge, UK) with water without chew-
ing. Th e sweet corn was used as a transit marker and volunteers 
were asked to report at what time the sweet corn fi rst appeared in 
their stool. 
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 Test drinks .  Th e unlabeled FODMAPs test drinks were given to 
each volunteer using a random assignment. Drinks consisted 
of 500  ml of water containing 40  g of either glucose (Dextrose 
monohydrate, Th ronton  & Ross, Huddersfi eld, UK), fructose 
(Holland  & Barrett, Nuneaton, UK), inulin (Oraft i HP, gift ed by 
DKSH Great Britain, Wimbledon, UK), or a mixture of 40  g glu-
cose with 40  g fructose. Th e glucose and fructose drinks were 
prepared by dissolving 40  g of sugar in boiling water (200  ml), 
followed by cold water (300  ml). Th e glucose and fructose drink 
mixture was prepared by mixing 40  g of each sugar and dissolv-
ing the mixture in 200  ml of boiling water, then making up to 
500  ml with cold water. Th e inulin drink was prepared by add-
ing 40  g of inulin to boiling water (500  ml) with constant stirring 
aft er which it was left  to chill. With the exception of the inulin 
drink, the drinks were sweet tasting, and a teaspoonful of PLj 
lemon juice (Healthy Food Brands, West Sussex, UK) was added 
to improve palatability, as well as to minimize the diff erences 
in taste. All drinks were served chilled at  ~ 4  ° C. Osmolality of 
each of the four test drinks was measured using a freezing point 
depression osmometer ( Table 1 ). 
 Other assessments .  All volunteers were asked to note the form 
and frequency of their bowel movements on a Bristol stool 
diary starting from 3 days before the study began to 3 days 
aft er the 4-week study ended. Th e study design and protocol 
were approved by the Ethics Committee of the University of 
Nottingham (Nottingham, UK) on 19 July 2011, and volunteers 
gave written informed consent. Th e study was carried out accord-
ing to Good Clinical Practice principles and registered on clinical 
trials.gov, identifi er NTC 01459406. 
 MRI protocol .  Images were acquired on a whole-body 1.5T 
scanner (Achieva, Philips Medical System, Best, Th e Netherlands ). 
Volunteers were positioned supine, head fi rst in the scanner with 
a 16-element SENSE (Philips Medical System) receive torso coil 
wrapped around the abdomen . Gastric emptying was meas-
ured using a balanced gradient echo sequence that acquired 
50 contiguous axial slices under 1 expi ration breath hold of 
16.5  s (TR / TE  =  2.98 / 1.49  ms, fl ip angle 80 ° 256 × 256 reconstr
ucted matrix, reconstructed in-plane resolution 1.56 × 1.56 × 5  mm 3 , 
SENSE 2.0). Th is imaging sequence yielded good contrast 
between the stomach ’ s contents and the other surrounding or-
gans. Th e amount of freely mobile water in the small bowel 
(SBWC) was measured as described and validated previously 
( 20 ) with a sequence that produces high-intensity signals from 
liquid regions of the body and dark signals for other tissues and 
organs. A coronal single-short turbo spin-echo sequence was used 
to acquire 24 slices with a single expiration breath hold of 24  s 
(TR / TE  =  8,000 / 320  ms, 512 × 512 reconstructed matrix, voxel size 
0.78 × 0.78 × 7  mm 3 ). Colonic gas was determined using a coronal 
dual-echo gradient echo sequence that acquired 24 contiguous 
slices 1.76 × 1.76 × 7  mm 3 with one expiration breath hold of 15  s 
(TR / TE1 / TE2  =  157 / 2.30 / 4.60  ms, 256 × 256 reconstructed matrix, 
voxel size 1.76 × 1.76 × 7  mm 3 ). Th is sequence allowed simultane-
ous collection of both in-phase and out-of-phase images, where 
voxels containing both water and fat are either bright or dark, 
respectively, and hence edges of diff erent organs had black outlin-
ing, making it easier to identify the intestinal outline. Each period 
of imaging lasted between 5 and 10  min, aft er which volunteers 
were removed from the scanner and allowed to sit upright. 
 Data analysis 
 Volumes of liquid and gas in the stomach were defi ned using an 
intensity-based region-growing algorithm developed in-house 
(IDL, Research Systems, Boulder, CO). Th e program identifi es 
pixels within a range of intensity levels connected to a user-defi ned 
starting point called a seed, with gaps fi lled using a morphological 
closing fi lter. Th e operator places the initial seed point, chooses 
the appropriate minimum (liquid) or maximum (air) intensity 
levels, and performs manual adjustments needed to defi ne the 
regions of interest fully. Th is was performed slice by slice and at 
each time point, and the total gastric volume was reported as the 
sum of liquid volume and intragastric gas. SBWC was measured 
using validated methods that have been previously described 
( 20 ). Colonic gas was determined aft er measuring colonic vol-
umes. Th e in-phase and out-of-phase coronal images were fi rst 
summed using in-house soft ware written in C. Regions of inter-
est were manually traced around the ascending, transverse, and 
descending segments of the colon on each image slice using Ana-
lyze 9 soft ware (Biomedical Imaging Resource, Mayo Foundation, 
Rochester, MN) and the regions were summed across the slices. 
Colonic gas was qualitatively identifi ed as regions that were com-
pletely black on the sum of the in-phase and out-of-phase images, 
and their total volume was assessed using histograms generated 
across the entire colon, with a maximum cutoff  threshold level for 
gas determined as the mean  +  1 s.d. of the gas regions manually 
identifi ed. For all data, the averaged data sets of volume against 
time were analyzed by calculating areas under the curves (AUCs) 
using the trapezoidal method. Th e diameter of the colon was 
assessed using a program developed in-house (IDL 6.4, Research 
Systems, Boulder, CO). Th e object maps of the three segments of 
the colon defi ned for colonic volume measurements (AC, TC, and 
DC) were loaded into the soft ware and a maximum-intensity pro-
jection of each segment was generated in the coronal plane. Th e 
analyzer then selected each individual segment and drew a central 
axis, along the length of the segment. Diameters of the colon were 
 Table 1 .  The osmolality and composition of the four drinks 
consumed by the volunteers during the study 
  Composition 
 Osmolality 
(mOsmol / kg) 
 Caloric 
value (kcal) 
 Glucose  Dextrose monohydrate  429  156 
 Fructose  Fructose  462  156 
 Fructan  Inulin a  36  60 
 Glucose  + 
 fructose 
 50 % dextrose mono-
hydrate  +  50 % fructose 
 917  312 
 a Inulin   >  99.5 % , glucose  +  fructose  +  sucrose  ≤ 0.5 % , average degree of poly-
merization (DP) of inulin  ≥ 23. 
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then generated perpendicular to this axis, along its whole length. 
Th e average of the largest 5 % diameters across each segment of 
the colon was then determined. Th e percent change from baseline 
was computed for the diameters of the ascending and transverse 
regions of the colon, and these values were compared with symp-
tom scores for gas and bloating as obtained from the volunteers. 
Th e diameter of the small bowel was also assessed by drawing line 
profi les using Analyze 9 in the D4 region of the duodenum by the 
ligament of Treitz. Although the investigator was not blinded to 
the solutions on the study day, the scans were coded with non-
sequential numbers for analysis and there was therefore no indi-
cation as to the solution consumed. Th e analysis was therefore 
eff ectively blinded. 
 Power and statistical analysis 
 Th e primary end point of the study was the postprandial AUC for 
SBWC for the four test meals. Previous work using mannitol and 
glucose ( 18 ) indicated that a 43 % increase in postprandial SBWC 
could be detected with  α  =  0.05 and 90 % power using  n  =  12. We 
studied fi ve more to allow for dropouts and incomplete scans. 
 Data are reported as mean (s.d.) (95 % CI) when normally 
distributed and median (range) for nonnormal distributions. 
Statistical tests were carried out using Prism 5 (GraphPad 
Soft ware, La Jolla, CA). Data normality was fi rst assessed using 
Shapiro – Wilk test of normality. Subsequent comparisons were 
performed using paired  t -tests and multicomparison rank tests. 
One-way and two-way analysis of variance was used to assess 
the signifi cance of diff erences between means, and statistical 
diff erences were considered signifi cant at  P  <  0.05. 
 RESULTS 
 Gastric volumes 
 Th e drinks consumed were easily visualized in the stomach using 
the imaging sequence. Th e AUC for gastric volume for each of 
the drinks is summarized in  Table 2 . As expected from its lower 
osmolality and reduced energy available for absorption based on 
caloric value ( 26 ) ( Table 1 ), of all the solutions tested, the inulin 
drink emptied from the stomach the quickest, with a signifi cantly 
lower AUC than glucose ( P  <  0.01) and the mixture of glucose and 
fructose ( P  <  0.001). However, the diff erence between the AUCs 
of fructose and inulin was not signifi cant, nor was the mean AUC 
for fructose diff erent from the AUC for glucose, the two solutions 
that had similar osmolalities and available energy. 
 Breath H 2 
 Of the 16 volunteers, 8 (50 % ) showed an increase in breath H 2 
of at least 20 p.p.m. aft er drinking fructose, whereas 13 / 16 (81 % ) 
showed a rise aft er drinking inulin. Inulin is poorly absorbed by 
everyone, and should have induced a breath H 2 response in all 
participants, unless they were non-H 2 or low H 2 producers. Th e 
three volunteers who showed no rise in breath H 2 were therefore 
excluded from subsequent analysis linking breath H 2 with MRI 
parameters. Th e breath H 2 concentration of the 13 H 2 produc-
ers across the study day is shown in  Figure 1 . Drinking fructose 
led to an immediate increase in average breath H 2 concentra-
tion that peaked at 75  min postprandial, aft er which concentra-
tions returned to just above baseline. Drinking glucose did not 
have any eff ect on breath H 2 concentrations, and addition of an 
equivalent amount of glucose to fructose signifi cantly reduced 
the concentration measured relative to fructose (mean (95 % CI) 
diff erence 7,800 (3,120 – 12,500) p.p.m. / min,  n  =  13  P  =  0.002) Th e 
trend across the study day for inulin was diff erent, rising slowly 
throughout the day without returning to baseline at the end of 
the study day. Indeed, inulin was the largest producer of breath 
H 2 over the study period , signifi cantly greater than both glucose 
(mean (95 % CI) diff erence 15,000 (9,500 – 20,400) p.p.m. / min, 
 n  =  13  P  <  0.0001) and fructose (mean (95 % CI) diff erence 7,800 
(940 – 3,300) p.p.m. / min,  n  =  13  P  =  0.027). Of the 16 volunteers, 
5 showed no increase in breath H 2 with fructose, whereas they 
showed an increase for inulin. 
 Small bowel water content 
 Th e volume of water in the small bowel increased aft er the 
fructose-containing drinks, peaking at 75  min postprandial, 
and returning to baseline by  t  =  195  min ( Figures 2 and 3 ). Aft er 
glucose and inulin, the small bowel water changed little. As 
indicated in  Table 2 , fructose signifi cantly increased the SBWC 
relative to glucose (mean (95 % CI) diff erence being 28 (17 – 40) 
l / min,  P  <  0.001), whereas inulin had little eff ect (mean (95 % CI) 
diff erence being 2 (  −  7 to 10) l / min,  P  >  0.7) compared with glu-
cose. Th e addition of an equivalent amount of glucose to fructose 
 Table 2 .  Mean AUCs for gastric contents, small bowel water content, breath H 2 , and colonic gas 
  Glucose  Fructose  Inulin  Glucose  +  fructose 
 Gastric contents, median AUC (range; l / min; 
 N =16) 
 56 (47 – 79)  48 (39 – 68)  37 (31 – 57)**  65 (51 – 82) 
 SBWC, median AUC (range; l / min;  N =16)  36 (11 – 132)  67 (37 – 111)**  33 (17 – 106)  46 (32 – 130)* 
 Breath H 2 , mean AUC (s.d.; p.p.m. / min;  N =13)  3,009 (3,000)  10,200 (7,800)**  18,000 (9,000)****  2,500 (2,000) 
 Colonic gas, mean AUC (s.d.; l / min;  N =15)  19 (14)  25 (17)  33 (20)*  21 (19) 
 AUC, area under the curve; H 2 , hydrogen; SBWC, small bowel water content. 
 * P  <  0.05 vs. glucose; ** P  <  0.005 vs. glucose; *** P  <  0.001 vs. glucose; **** P  <  0.0001 vs. glucose. 
 All data were collected over 5  h from volunteers who drank glucose, fructose, inulin, and a mixture of glucose and fructose. 
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the two groups aft er fructose alone (mean (95 % CI) diff erence 
being 3,500 (  −  22,000 to 29,000) l / min,  P  =  0.77) or aft er drinking 
the mixture of glucose and fructose (mean (95 % CI) diff erence 
being 1,800 (  −  29,000 to 33,000) l / min,  P  =  0.90). 
 Colonic gas 
 Colonic gas analyses were performed on a data set of 15 volun-
teers, as the colon of 1 volunteer could not be segmented 
reliably from the images. Th e increase of gas in the colon aft er drink-
ing inulin is easily visualized on the MR images 255  min postprandial 
( Figure 5 ), as well as in the volumes across the study day ( Figure 6 ). 
In  Figure 5 , some regions of the colon such as the sigmoid colon are 
not well seen initially ( Figure 5a ), but can be seen later at  t  =  255  min 
( Figure 5b ) as a result of luminal distension via gas production . Th e 
area under the curves (AUCs) for each drink over the entire study 
day are shown in  Table 2 . Inulin consumption led to the greatest 
production of colonic gas, signifi cantly greater than both glucose 
(mean (95 % CI) diff erence being 15 (2 – 28) l / min,  n  =  15,  P  <  0.05) 
and the mixture of glucose and fructose (mean (95 % CI) diff erence 
being 12 (2 – 23) l / min,  n  =  15,  P  <  0.05). Th ere was no signifi cant 
diff erence between fructose and inulin (mean (95 % CI) diff erence 
being 8 (  −  5 to 22) l / min,  n  =  15,  P  >  0.20). 
 Small and large bowel diameters 
 Th e percent change from baseline for the diameter of the small 
bowel and the ascending and transverse regions of the large bowel 
was assessed for each of the drinks. For the small bowel, this value 
increased across the study day ( Figure 7 ), but no signifi cant dif-
ference between the drinks was found using two-way analysis 
of variance ( P  >  0.7). Th e percent change from baseline of the 
colon peaked at 30 % (43 % ) in the transverse region at 255  min 
aft er drinking fructan as compared with glucose 8 % (21 % ) at the 
same time . Th ere was less change noticed in the ascending colon: 
the highest change from baseline was 18 % (20 % ) at 75  min aft er 
drinking fructose as compared with 4 % (26 % ) at the same time 
for glucose. Using Spearman ’ s rank correlation coeffi  cient, there 
were no correlations between bloating, pain, and gas and the per-
cent change from baseline of the diameter of any region of the 
colon for any of the drinks. 
 Other assessments 
 Data for stool diaries, sweet corn transit, and results from symp-
toms, HADS, and PHQ15 questionnaires are all summarized in 
 Table 3 . No signifi cant between-drink diff erences were found in 
the symptoms questionnaires ( P  >  0.5), although a quarter of the 
volunteers reported a single episode of loose stools aft er the inu-
lin. Closer examination of the  “ gas ” symptoms showed 2 groups 
of subjects: one ( “ asymptomatic ” ) who reported none (score of 1), 
and the other ( “ symptomatic ” ) who reported mild (score of 2), 
moderate (score of 3), and, in a single instance, severe (score of 4) 
symptoms. For the second group, a correlation was observed 
between the volume of gas in the colon and gas symptom ( r  =  0.59, 
 P  <  0.0001). Th ere was no correlation between bloating and SBWC. 
Stool form on the study day and the day aft er was averaged and 
reported for each drink. Baseline values were obtained from an 
reduced the SBWC, but this decrease failed to reach conventional 
statistical signifi cance (mean (95 % CI) diff erence being 16 (  −  2 to 
35) l / min,  P  =  0.08) compared with fructose. 
 Based on breath H 2 responses, the volunteers were then split into 
two groups, 8 fructose H 2 negative and 8 fructose H 2 positive, and 
the diff erences in their SBWC aft er drinking both the fructose and 
the mixture of glucose and fructose were examined.  Figure 4a,b 
illustrates that there is no signifi cant diff erence in SBWC between 
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 Figure 1 .  Breath hydrogen (H 2 ) concentrations throughout the study day 
for the 13 H 2 producers after drinking each of the four drinks: glucose, 
fructose, fructan, and glucose  +  fructose mix. The time of drinking 
( t  =  0 min) is highlighted in the chart. Values are mean concentration 
(p.p.m.) ± s.e.m. 
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 Figure 2 .  Small bowel water content (SBWC) throughout the study day 
for 16 volunteers after drinking each of the four drinks: glucose, fructose, 
fructan, and glucose  +  fructose mix. The time of drinking ( t  =  0 min) is 
highlighted in the chart. Values are mean volume (ml) ± s.e.m. 
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average of the stool form 5 days before the study. No signifi cant 
diff erences were found with stool data, including form ( P  >  0.7) 
or transit ( P  >  0.2). With the exception of 1 volunteer, the scores 
for the HADS questionnaires were  ≤ 7. Similarly, all volunteers 
scored   <  6 on the PHQ15, with the exception of 1 volunteer who 
had had a car crash shortly before completing the questionnaire. 
 DISCUSSION 
 Th is study was designed to investigate the volumes of the diff erent 
regions of the gastrointestinal tract aft er a FODMAP challenge 
using unique MRI measures to make the assessment without 
disturbing the normal physiology, a feature that previous intuba-
tion techniques could not avoid. Th e data confi rmed the initial 
hypothesis that fructose, being both osmotically active and rela-
tively poorly absorbed, substantially increases small bowel water, 
nearly doubling the volume compared with the well-absorbed 
glucose drink. Th e drinks compared had very diff erent osmo-
lalities and, based on the AUCs for gastric volume, emptied at 
diff erent rates. Th is did not account for the diff erence in SBWC 
as  Tables 1 and 2 show that the inulin drink with the lowest osmo-
lality and lowest gastric AUC had the smallest SBWC. 
 All test drinks had zero sodium content and although this 
would have been increased a little by endogenous secretions, 
on entering the small bowel they would create a steep sodium 
gradient between the lumen and the interstitial fl uid, down 
which sodium and associated chloride and water would pass 
as clearly shown by previous perfusion studies ( 27 ). Although 
glucose will then stimulate sodium absorption by co-transport, 
the poorly absorbed osmotically active fructose cannot do this, 
thus increasing the water and sodium content of the small intes-
tine that is trapped by the high osmolality. Th ere are no stud-
ies of intestinal fl uid in humans aft er fructose alone. However 
lactose in lactase-defi cient individuals would be expected to 
behave similarly to fructose in normal subjects, being of similar 
molecular size and poorly absorbed. Intubation studies in such 
individuals showed a profound dilution of intestinal contents 
aft er a lactose drink as fl uid enters the small intestine along 
with sodium ( 17 ). Inulin, being of low osmolality, allows rapid 
absorption of water down the osmotic gradient to the intersti-
tial fl uid and hence would not be expected to increase small 
bowel water. 
 Th e majority of ingested inulin, being relatively unabsorb-
able in the small intestine, enters the colon and hence had the 
Gall
bladder
Stomach
Small bowel
Glucose Fructose Glucose + fructose Fructan
 Figure 3 .  A representative example of coronal images of the small bowel from a single volunteer at 75  min after drinking each of the test drinks: 
( a ) glucose, ( b ) fructose, ( c ) glucose  +  fructose, and ( d ) fructan. The stomach and gall bladder are also visualized in these images. 
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 Figure 4 .  The comparison between small bowel water content (SBWC) for 8 subjects who produced hydrogen (H 2 positive) after fructose and 8 who did 
not (H 2 negative) after drinking ( a ) fructose and ( b ) glucose  +  fructose. Values are mean concentration (ml) ± s.e.m. 
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fructose suggests that either hydrogen production is an unreli-
able guide to malabsorption or that fructose may increase fl uid 
volume in the small bowel without overfl owing into the colon, 
presumably because the terminal ileum can compensate for poor 
absorption more proximally. Fructose is transported across the 
intestinal epithelium via the facilitative transporter GLUT5 ( 28 ), 
a low-affi  nity but high-capacity transporter specifi c to fructose, 
and also GLUT2, a hexose facilitative transporter ( 21 ). Previous 
reports have highlighted that the addition of glucose to fructose 
improves its absorption ( 14,15,29 ), although the mechanism 
has not been defi nitively determined. Th ese observations led to 
the second hypothesis that adding an equivalent amount of glu-
cose to fructose would reduce malabsorption of fructose in the 
small bowel. We found that there was a reduction in small bowel 
water content, and although this was not statistically signifi cant, 
there was a signifi cant reduction in the breath H 2 levels, pos-
sibly indicating a reduction in malabsorbed fructose reaching 
the colon. 
 Th e study was designed to investigate the eff ect of the non-
osmotically active inulin compared with the osmotically active 
fructose on the small bowel and colon. Although inulin is restricted 
in the low-FODMAP diet, its intake is negligible in a normal diet 
compared with fructans of shorter-chain length such as kestose 
and nystose. Inulin-type fructans, such as the ones used in this 
study, resist digestion in the upper gastrointestinal tract because 
of the lack of an enzyme to break their fructosyl – fructose glu-
cosidic linkages ( 30 ). As a result, they pass through to the colon 
where they are fermented to a mixture of gases and short-chain 
fatty acids. Although shorter-chain fructans are expected to exert 
an osmotic eff ect on the small bowel, we hypothesized that unlike 
fructose, inulin would exert its main eff ect in the colon rather than 
the small bowel. Th e noninvasive MRI methods showed this was 
greatest eff ect on breath hydrogen concentration, with 13 of the 
16 volunteers showing a rise of   >  20 p.p.m. in breath hydrogen. 
Five of those 13 volunteers who had colonic bacteria capable 
of producing hydrogen from inulin showed no increase aft er 
drinking fructose, suggesting they did not malabsorb fructose. 
Surprisingly, these volunteers did not show any smaller rise in 
the volume of water in the small bowel compared with those 
who displayed a rise in breath hydrogen aft er fructose, nor was 
their response to drinking the glucose  +  fructose drink diff erent. 
Th e hydrogen response is of course an indirect assessment of 
fructose malabsorption that assumes all microbiota do produce 
hydrogen from fructose. Th e similarity in the small bowel water 
response of those who did and did not produce hydrogen aft er 
Liver
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Transverse colon
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Sigmoid
colon
 Figure 5 .  A representative example of coronal images through the large 
bowel of a single volunteer, comparing the visibility of gas in the colon 
at ( a ) baseline  t  =    −  45  min and ( b ) 255  min after drinking the fructan test 
meal . 
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correct, as the water in the small bowel aft er drinking inulin did 
not diff er signifi cantly from that produced aft er drinking glucose, 
but the volume of gas in the colon and the concentration of breath 
H 2 rose the most aft er drinking inulin, and was signifi cantly higher 
than aft er glucose ingestion. It would be of interest in the future to 
examine fructans of shorter chain length more typical of dietary 
constituents to determine their diff ering eff ects on small and large 
bowel contents. 
 It has been hypothesized that FODMAPs are able to trigger 
gastrointestinal symptoms by luminal distension, predominantly 
through gas production ( 10 ). Th is study has demonstrated that 
FODMAPs had a signifi cant impact on the production of gas-
trointestinal gas, with fructose and inulin producing signifi cantly 
more gas than glucose and the mixture of glucose and fructose. 
Assuming that colonic gas causes luminal distension, the percent 
changes from baseline of diameter of the ascending and transverse 
regions of the colon were calculated, and an attempt was made 
to correlate this luminal diameter with the volunteers ’ reported 
symptoms of abdominal gas, bloating, and abdominal pain. Th ere 
were no correlations, similar to previous studies where compari-
sons of gas volume with abdominal pain and distension showed 
no correlation with both patients and healthy volunteers ( 31,32 ). 
Th is suggests that the normal colon relaxes and accommodates 
gas without causing symptoms. Th ere was a weak but signifi cant 
correlation between the volume of gas in the colon and the gas 
symptom score for the  “ symptomatic ” subset of the volunteers, pre-
sumably refl ecting gas passed through the colon and expelled. In a 
study investigating the relationships among lactulose breath test, 
intestinal gas volume and gastrointestinal symptoms (bloating, 
pain, and fl atulence) in patients ( 33 ), it was noted that although 
there were correlations between symptoms and gas volume score, 
this correlation was weak. Interestingly, it has been reported that 
abdominal discomfort is determined by the distribution of gas 
within the gut, based on a study that suggests that distending the 
small bowel produces more abdominal symptoms, whereas the 
colon seems able to accommodate large volumes of gas without 
causing abdominal discomfort ( 34 ), which may explain why few 
correlations were noted between symptoms and colonic measure-
ments. In addition, most healthy subjects seem able to tolerate 
large gas loads unlike patients with functional gastrointestinal 
disorders ( 34,35 ), suggesting a further reason for the weak cor-
relations in healthy volunteers. Th e known increased sensitivity of 
IBS patients to intestinal distension makes it likely that pain and 
discomfort aft er a FODMAP challenge might well correlate with 
increases in colonic diameters. 
 Th e MRI technique used to measure the colonic gas volumes 
has not been validated, and it is likely that the absolute volumes are 
not accurate as smaller gas volumes will have been overestimated 
because of partial volume errors when setting a signal threshold on 
small pockets of gas. However, trends in gas volume changes will 
still be valid, particularly as each subject acted as their own con-
trol, although variations in scanner adjustment between scan ses-
sions or interobserver variability in the analysis will have acted to 
reduce the power with which the parameter could detect changes. 
Further validation work is required to determine the accuracy and 
interobserver variability of the gas volume measurements. 
 MRI off ered an advantage in this study, as it allowed us to visu-
alize fructose and inulin malabsorption that had previously only 
been observed in ileostomists. It shows the very diff erent behav-
ior of fructose and inulin. Future studies will focus on how these 
changes relate to symptoms following ingestion of fructose and 
fructans of varying molecular weight in suff erers of functional gas-
trointestinal disorders with the aim of tailoring diets more specifi -
cally to individual patients. 
 Table 3 .  Other assessments carried out during the study ( N =16) 
  Glucose  Fructose  Inulin  Glucose  +  fructose 
 Stool form a (average ± s.e.m.)  3 ± 0.2  4 ± 0.2  4 ± 0.4  4 ± 0.3 
 Transit time average ± s.e.m. (h)  20 ± 5  21 ± 11  22 ± 5  19 ± 6 
 Symptoms (average ± s.e.m.) 
  Gas  1.03 ± 0.01  1.11 ± 0.02  1.26 ± 0.04  1.11 ± 0.04 
  Bloating  1.06 ± 0.02  1.06 ± 0.02  1.03 ± 0.01  1.07 ± 0.04 
  Belching  1.07 ± 0.02  1.04 ± 0.01  1.02 ± 0.01  1.07 ± 0.02 
  Nausea  1 ± 0  0.01  1 ± 0  1.03 ± 0.02 
  Abdominal pain  1.02 ± 0.01  1.08 ± 0.01  1.01 ± 0.01  1.03 ± 0.02 
  Diarrhea  1 ± 0  1.03 ± 0.02  1.05 ± 0.02  1.03 ± 0.02 
 HADS anxiety  3 ± 0.8 
 HADS depression  2 ± 0.7 
 PHQ15  2 ± 0.5 
 HADS, Hospital Anxiety and Depression Scale; PHQ15, Patient Health Questionnaire 15. 
 a Averaged over the study day and subsequent day. 
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 Study Highlights 
 WHAT IS CURRENT KNOWLEDGE 
 3 Fructose and especially fructans are poorly absorbed in the 
small intestine. 
 3 Above a certain threshold dose of fructose, a proportion 
enters the colon where fermentation leads to an increase in 
colonic gas with symptoms of fl atulence and bloating. 
 3 Irritable bowel syndrome (IBS) symptoms of bloating, 
gas, and abdominal pain may benefi t from low-FODMAP 
(Fermentable Oligo- Di-, Mono-saccharides And Polyols) 
diets that reduce poorly absorbed, short-chain carbohydrates, 
including but not limited to fructose and fructans intake. 
 WHAT IS NEW HERE 
 3 Fructose, being an osmotically active monomer, causes 
marked distension of the small intestine that is not seen 
with the polymeric inulin. 
 3 Inulin causes a more sustained rise in colonic gas that 
increases the luminal diameter of the colon. 
 3 This study suggests that it will be important to separately 
study the impact of fructose and high-molecular-weight 
fructans in IBS patients as this may allow a more selective 
tailoring of diets for specifi c symptoms.  
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